Biostimulation / 06

Radiesse: understand the product behind the plan

Radiesse is a calcium hydroxylapatite dermal filler. Its FDA indications depend on the specific product and use; your provider should name both before treatment.

Book an appointment

Adult woman’s cheek and lower-face skin in warm light

A brand name alone does not tell you whether a proposed placement is approved or suitable. Ask for the exact Radiesse product, site, and rationale.

Product and placement

The FDA lists calcium hydroxylapatite as a dermal filler material, and its Radiesse record documents facial wrinkle and fold indications. Product variations and later approvals should be checked against current labeling.

The clinical tradeoffs

Ask how this product compares with hyaluronic acid filler or Sculptra for your concern, including reversibility and complication management.

Illustrative room prepared for an aesthetic consultation

Before and after

Discuss health history, expected swelling or bruising, aftercare, and who will respond to an urgent problem.

A material decision, not just a brand decision

Calcium hydroxylapatite is not the same material as hyaluronic acid filler. Ask whether the specific treatment goal would be better served by a different material, and how the practice would respond if the result or a complication needs attention. The answer should be specific to the product and injection site being proposed.

TAKE THESE WITH YOU

Questions for a clinician

Which Radiesse product and indication apply?
Why choose this material for my anatomy?
How would a complication be managed?

Sources: FDA: Radiesse approval record (opens in a new tab) · FDA: Dermal fillers (opens in a new tab) · FDA: Dermal filler dos and don’ts (opens in a new tab)

THE NEXT STEP

Ready to talk about your options?

Request an appointment for the treatment you want to explore. We will contact you to confirm provider availability, visit details, and the location.